- Home
- GALT vs ONTF Comparison
GALT vs ONTF Comparison
Compare GALT & ONTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | ONTF |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.3M | 212.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GALT | ONTF |
|---|---|---|
| Price | $6.13 | $6.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | ★ 440.3K | 210.9K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $141,348,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $4.35 |
| 52 Week High | $6.66 | $7.04 |
Technical Indicators
Market Signals| Indicator | GALT | ONTF |
|---|---|---|
| Relative Strength Index (RSI) | 57.01 | 61.96 |
| Support Level | $5.10 | $5.92 |
| Resistance Level | $6.32 | $6.13 |
| Average True Range (ATR) | 0.52 | 0.17 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 66.03 | 88.04 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.